Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

By sjmartinez • June 17, 2024

Bolla E, Semb AG, Kerola AM, Ikdahl E, Petri M, Pons-Estel GJ, Karpouzas GA, Sfikakis PP, Quintana R, Misra DP, Borba EF, Garcia-de la Torre I, Popkova TV, Artim-Esen B, Troldborg A, Fragoso-Loyo H, Ajeganova S, Yazici A, Aroca-Martinez G, Direskeneli H, Ugarte-Gil MF, Mosca M, Goyal M, Svenungsson E, Macieira C, Hoi A, Lerang K, Costedoat-Chalumeau N, Tincani A, Mirrakhimov E, Acosta Colman I, Danza A, Massardo L, Blagojevic J, Yılmaz N, Tegzová D, Yavuz S, Korkmaz C, Hachulla E, Moreno Alvarez MJ, Muñoz-Louis R, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries. Lancet Rheumatol. 2024 Jun 10:S2665-9913(24)00090-0. doi: 10.1016/S2665-9913(24)00090-0. Epub ahead of print. PMID: 38878780.

Tags: Harbor UCLA, Publications, Rheumatology

Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections

Singh S, Youssef EG, Barbarino A, Hautau H, Nabeela S, Gebremariam T, Alkhazraji S, Ostroff G, Christensen D, Cochrane T, Ibrahim AS. Next-generation Candida albicans[...]

Sodium-Glucose Cotransporter-2 Inhibitors and Ketoacid Diets for Diabetic Kidney Disease

Kopple JD. Sodium-Glucose Cotransporter-2 Inhibitors and Ketoacid Diets for Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2025 Dec 12. doi: 10.2215/CJN.0000000958. Epub ahead of[...]

Imaging Inflammation: Epicardial Fat Density as an Imaging Marker of Cardiovascular Risk

Abbas N, Budoff M, Lakshmanan S. Imaging Inflammation: Epicardial Fat Density as an Imaging Marker of Cardiovascular Risk. Heart Int. 2025 Nov 24;19(2):29-34. doi: 10.17925/HI.2025.19.2.4.[...]